Objective: The neonatal mortality rate is disproportionately influenced by preterm infants and does not reflect the rate in full-term infants. Our objectives were to estimate the full-term neonatal mortality rate and to identify causes of death in full-term infants during the first month of life.
Introduction
Data on mortality of full-term infants are not readily available. Traditionally, an annual summary of vital pediatric statistics 1 is published and includes neonatal and infant mortality rates (rates of death between birth and 28 days of age and between birth and 1 year of age, respectively). The neonatal mortality rate is disproportionately influenced by the preterm population and is mostly determined by infants of very low birth weight. Thus, the published neonatal mortality rate reflects neither the rate nor the causes of mortality in full-term infants. Accurate information on the causes of mortality in full-term infants is needed to identify interventions aimed at reducing mortality in this population.
Our aim was to calculate the full-term mortality rate (FTMR) of infants born in a tertiary care center and to identify the causes of mortality in full-term infants.
Methods
Rabin Medical Center, Petah Tiqva, Israel is a large medical center situated in a populated urban area in the center of Israel with approximately 8500 deliveries per year and serves both as a tertiary care center and as a regional hospital. The major pediatric hospital in Israel, Schneider Children's Medical Center is adjacent to, and responsible for all neonates born in Rabin Medical Center. Our population base is composed of a heterogeneous population of different religions, ethnicities and socio-economic diversities and also includes religious Jews and Moslems who due to their religious beliefs often refrain from performing abortions.
Infants born at term, 37 to 42 weeks of gestation (259 to 293 days post-conception), were identified by a computer search of the databases of Rabin and Schneider Medical Centers and was supplemented by a manual search of the records of the neonatal departments of both centers. All full-term newborns that died during the neonatal period (birth to 28 days of age) during the period January 2000 through December 2005, inclusive, were retrospectively identified. Demographic data, maternal illness and medication use, birth weight and causes of death were abstracted from the medical records. Infants that were small for gestational age and low birth weight were identified using the definitions of birth weight less than 3rd percentile and birth weight less than 2500 g, respectively. The causes of death were reviewed and determined independently by two senior neonatologists. Causes of death were classified similarly to the Tulip classification 2 into three major groups: congenital anomalies (single organ, syndrome/chromosomal abnormality), labor complications and acquired causes (infectious or other). The study was approved by the Institutional Review Board.
Results
During the 6-year study period, the number of live births in Rabin Medical Center ranged from 7902 to 8544 annually, and totaled 50 886. This number represents approximately 6.2% of the total live births in Israel. 3 Of the infants born, 44 703 (87.8%) were fullterm, 5035 (9.9%) were preterm and 1148 (2.3%) were post-term. During the period of study, there were 31 neonatal deaths of fullterm infants (16 male, 15 female), representing a mean mortality rate of 0.69 deaths per 1000 live full-term births (Table 1) . There were no deaths of infants delivered post-term. Of the 31 deaths, 29 were the consequence of singleton deliveries and two were the result of two different twin pregnancies. The mean birth weight of full-term infants that died was 2903 g (s.d., 577 g, range: 1580 to 4280 g). The rates of low birth weight and small for gestational age among newborns that died were more than twice that of the general full-term population: 23% vs 10.9% and 6% vs 2.5%. Of the 31 infants, 18 (58%) were delivered spontaneously, 4 (13%) by vacuum extraction, 9 (29%) by cesarean section and none by forceps delivery. Eight infants were given low Apgar scores (<7) at 1 min of life, four remained low at 5 min and in one case, these data were not recorded. Death occurred at a mean age of 7.6 days (s.d., 5.8 days, range: 1 to 26 days). Maternal diabetes was present for a single infant that died following a traumatic delivery. No other maternal illnesses were identified. First-trimester exposure to medications was not identified for any infant. Medical history was negative for substance abuse for all of the mothers. No difference in distribution of deaths was noted between weekdays and weekend days.
Congenital causes were responsible for 83.9% of deaths ( Table 2 ). The leading cause of death among full-term infants was cardiac malformations (54.8%). The most common types of cardiac anomalies among full-term infants that died were: hypoplastic left heart (59% of cardiac anomalies), transposition of great arteries (24% of cardiac anomalies), coarctation or other aortic abnormalities (30% of cardiac anomalies) and single ventricle (6% of cardiac anomalies). A number of infants had more than one anomaly. None of the infants with congenital anomalies were born to diabetic mothers. One infant with a congenital disease (Hirschsprung's disease) died after developing fulminant enterocolitis. Trisomy-18 was diagnosed in two of four infants that died of a chromosomal abnormality or syndrome.
Acquired causes of deaths were responsible for 5 of 31 deaths (16.1%). Of the five deaths, three were due to hypoxic-ischemic encephalopathy, one to a brain hemorrhage and one to infection (pneumonia). Labor complications were associated with 4 of 31 deaths (12.9%). Of the three infants that died of hypoxic-ischemic encephalopathy, two were delivered vaginally and a third by an emergency cesarean section. The infant that died of a brain hemorrhage identified within hours of birth was delivered by a vacuum extraction.
Discussion
During the study period, we found the FTMR to be 0.69 per 1000 live births, which translates to one death for every 1470 births. This figure is substantially lower as reported previously. 4 Most deaths were related to congenital anomalies and not to acquired causes. Deaths attributable to congenital anomalies were responsible for nearly 65% of full-term infant deaths, a figure that is threefold that found in a population composed of both term and preterm infants. 5 The neonatal mortality rate is derived from the population of all newborn infantsFpreterm and full-term alike. In the United States, during the years 1995 to 1997, the FTMR was 1.49 deaths per 1000 live births. This figure was estimated from birth-weight/ gestational age-specific mortality rates. 4 Full-term newborns are the vast majority of births but possibly because they are considered low-risk births, data regarding mortality in this population are neither accurate nor up to date. The FTMR in the present study is lower than previous reports, but the magnitude of decrease cannot 
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A Amir et al be assessed because the previously published rates were based on estimation. A decreased FTMR may be the result of advances in neonatal care made during the last decade 6 and may also be related to the good prenatal care practiced in Israel. Standard prenatal care in Israel is covered by national health insurance for all the population and includes: triple-test, glucose challenge test, fetal-targeted ultra-sound examination and when indicated, fetal echocardiography and selective termination of pregnancies affected by severe congenital anomalies.
Intervention aimed at reducing neonatal mortality should target the most common causes. The vast majority of deaths were due to congenital causes: congenital malformations, congenital syndromes and chromosomal abnormalities. Thus, reducing mortality in the full-term newborn can be achieved by early detection of congenital anomalies or chromosomal abnormalities during pregnancy. As in our report, Yang et al. 7 recently found that cardiovascular defects were the most common congenital cause of neonatal death. Folic acid supplementation has long been known to reduce neural tube defects; new evidence suggests association of folic acid or multivitamin supplementation with a reduced risk of congenital cardiac malformations, but further investigation is still required. 8 Many congenital abnormalities can be diagnosed by use of fetal sonographic examination and/or amniocentesis. Early detection of congenital abnormalities is important to optimize immediate postpartum treatment, or to abort the fetus. Optimizing post-partum treatment can be achieved by labor and delivery in tertiary care centers that specialize in treatment of congenital birth defects. Although Israel provides good prenatal care, congenital malformations are still an important cause of infant mortality. This is in part related to religious beliefs that prevent performing abortions or seeking of optimal prenatal care. The task therefore is to educate further the community to use available prenatal diagnoses.
Routine Streptococcus group B prophylaxis has been the standard of care during the study period. This likely resulted in no deaths that were related to Streptococcus group B. Only one infant died of infectious cause, thus interventions aimed at reducing infections are unlikely to have a significant impact on mortality of full-term infants. Early recognition of high-risk births and referral of these deliveries to a tertiary care center may help reduce mortality from labor complications.
Low Apgar scores are known to correlate with higher mortality rates in full-term infants, 9 but in the present study, Apgar scores were not helpful in identifying most full-term infants that died. This can be explained by the fact that death of only a small number of newborns was related to labor complications and that many infants with congenital anomalies have a normal Apgar score. For the newborns with acquired causes of death, the 5 min Apgar score remained low for 4 of 5 infants.
In conclusion, mortality of full-term neonates can and should be minimized mainly by improving prenatal care. To achieve a significant improvement in the FTMR, efforts should focus on prevention of birth defects, which are the dominant cause of mortality.
